Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and more

This week's roundup on the region's life sciences industry includes one company securing two FDA approvals, a South Jersey institution receiving a $12 million research grant, and more. Here's the rundown: Incyte Corp. The Wilmington biotechnology company started the week receiving marketing clearance from the Food and Drug Administration for Opzelura, the company's topical cream for mild-to-moderate atopic dermatitis — a chronic skin disease that affects more than 21 million people in the Unit ed…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news